Guilin Sanjin Pharmaceutical Co., Ltd.

¥18.20As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002275Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 2.85%
Div yield 2.75%
ROE 12.77%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.08
PE TTM 25.27
TSR TTM 26.17%
Mkt cap ¥10.69B
ROIC 18.99%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥22
21.99%
(86.51%)
Hold 0|0|4|2|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.28
0.28
0.27
0.28
26.42%
17.49%
3.01%
(5.49%)
Revenue¥M
861.8
869.2
917.7
934.6
8.92%
7.78%
7.43%
5.92%
Peers (US$1.603B)
Cap (US$)
PE
1.622B
23.44x
1.622B
97.95x
Capital
TTM
5Y
10Y
Leveragex
2.476
0.798
0.732
EBIT/Intx
1.044
0.646
0.667
Own earn%
16.34
86.26
77.67
Sh yield%
52.93
39.42
39.05
Owners
Insiders/Inst%
2.89
25.29
Short interest%
4.55
SBC / revenue%
1.32
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
0–4
$1 testx
—
Incr. ROIC%
0